Wednesday, June 10

Browsing: FirstinWorld

Survivors

First-in-World Leukemia Trial Aims to Leave No Patients Behind

By NewsCancerFebruary 23, 20260

In February 2026, Ashkan Emadi, MD, PhD, and colleagues announced that the first patient in the world had undergone treatment…

Support

First-in-World Trial Explores Subcutaneous Blinatumomab in Rare Leukemia

By NewsCancerFebruary 19, 20260

In a conversation with CancerNetwork®, Ashkan Emadi, MD, PhD, discussed the background of a first-of-its-kind phase 2 trial (NCT07222579) investigating…

► Necessary Cookies Always Active

Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.

► Functional Cookies Remark

Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.

► Analytical Cookies Remark

Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.

► Advertisement Cookies Remark

Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.

What's Hot

Hetairos is a histology-based artificial intelligence model for predicting central nervous system tumor methylation subtypes

How I Stopped Being the Victim of My Own Story

Actor Tyler Mane reveals he is having treatment for rare male breast cancer | US news

Browsing: FirstinWorld

First-in-World Leukemia Trial Aims to Leave No Patients Behind

First-in-World Trial Explores Subcutaneous Blinatumomab in Rare Leukemia

Hetairos is a histology-based artificial intelligence model for predicting central nervous system tumor methylation subtypes

How I Stopped Being the Victim of My Own Story

Actor Tyler Mane reveals he is having treatment for rare male breast cancer | US news

Investigators Halt Phase 3 Trial of Sacituzumab Govitecan Combo in NSCLC

Hetairos is a histology-based artificial intelligence model for predicting central nervous system tumor methylation subtypes

How I Stopped Being the Victim of My Own Story

Actor Tyler Mane reveals he is having treatment for rare male breast cancer | US news

Investigators Halt Phase 3 Trial of Sacituzumab Govitecan Combo in NSCLC

Latest Post

Hetairos is a histology-based artificial intelligence model for predicting central nervous system tumor methylation subtypes

How I Stopped Being the Victim of My Own Story

Actor Tyler Mane reveals he is having treatment for rare male breast cancer | US news

Subscribe to Updates

What's Hot

Browsing: FirstinWorld